Affimed N.V. (AFMD) Financials
AFMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 127.5 million | 46.6 million |
2023-06-30 | 146.5 million | 38.9 million |
2023-03-31 | 183.1 million | 46.7 million |
2022-12-31 | 215.2 million | 51.1 million |
AFMD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -22.7 million | 2.0 million |
2023-06-30 | -36.2 million | 3.5 million |
2023-03-31 | -36.2 million | 4.5 million |
2022-12-31 | -33.7 million | 4.6 million |
AFMD Net Income
No data available :(
AFMD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 103.2 million | - | 8.0 million |
2023-06-30 | 130.5 million | - | 351209 |
2023-03-31 | - | - | 488323 |
2022-12-31 | 204.2 million | - | 613854 |
AFMD Shares Outstanding
AFMD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 3.4 million | 22.8 million | 5.7 million | - |
2023-06-30 | 3262 | 27.5 million | 6.8 million | - |
2023-03-31 | 8720 | 32.2 million | 7.5 million | - |
2022-12-31 | 432488 | 35.9 million | 9.2 million | - |
AFMD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.1 million | - |
2023-06-30 | 1.5 million | - |
2023-03-31 | 4.9 million | - |
2022-12-31 | 12.0 million | - |
AFMD
Price: $5.38
52 week price:
Earnings Per Share: -8.56 USD
P/E Ratio: -0.62
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.5 million
Ebitda: -9.1 millionMarket Capitalization: 93.6 million